Brian G. Murphy
Chairman of the Board
General Partner of Commerce
Health Ventures
Mr. Murphy is a General Partner of Commerce Health Ventures, Partner of NewSpring Ventures, and a Partner of NewSpring Capital, with more than 20 years of corporate management and development experience, focused primarily in healthcare services. He has a strong background in business strategy, investment structuring, organizational growth, and negotiation of mergers and acquisitions.  
More Info

Mary Del Brady
President & CEO, RedPath Integrated Pathology, Inc.
Mary Del Brady is an entrepreneur whose 30 years of professional experience include the founding and ownership of several companies in the services and biotechnology industries.  She has also held an executive role within an academic health system, was president of a national association of business owners with international responsibilities and has served as director/advisor for numerous not-for-profit and for-profit boards. More Info

Barbara Handelin, PhD
Director Diagnostics, GM Computational Biology
DNA Print Pharmaceuticals
Dr. Handelin is a seasoned biotech business executive and board certified Molecular Geneticist who has pioneered the responsible application of genetics to clinical medicine and drug development research over a 16 year career. More Info

Peter G. Kleinhenz
Managing Director of CID Capital
Peter Kleinhenz is a Managing Director of CID Capital. He has been actively involved in technology-based businesses as an entrepreneur, consultant, and investor for over twenty-five years and has provided leadership for new venture formation in the life sciences sector for over 20 years. Peter leads the firm's investments in health care technology.
More Info

Dennis M. Smith Jr., M.D.
Consultant
Dr. Smith possesses over 25 years of experience in healthcare management, the outreach laboratory business, pathology, laboratory medicine, and blood banking. He is a board-certified clinical and anatomic pathologist and transfusion medicine specialist. More Info

Sydney D. Finkelstein
Founder and Chief Scientific Officer,
RedPath Integrated Pathology, Inc.
Dr. Finkelstein founded RedPath after having spent 20 years as a practicing academic surgical pathologist holding appointments as Associate and then Full Professor at the University of Pittsburgh (1993-1997, 1998-2002) and at Hahnemann University (1983-1993).  Dr. Finkelstein is a nationally recognized expert in both Gastrointestinal Pathology and Solid Tissue Molecular Pathology. He has published over 142 scientific manuscripts in peer-reviewed journals and has presented his work at international forums. Dr. Finkelstein brings together the unique attributes of creative innovative molecular pathology development as well as solid foundational understanding of the practice of modern surgical pathology practice. More Info

Rajesh U. Kothari, CFA
Co-Founder & Managing Director, Seneca Partners
With over fifteen years of investment and transaction experience, Mr. Kothari has spent his career analyzing, structuring, negotiating, monitoring and exiting a variety of transactions in the public and private markets.  Mr. Kothari is a co-founder and Managing Director of Seneca Partners, a venture capital and merchant-banking firm.  In addition to assisting companies with mergers, acquisitions, divestitures and corporate finance activities, Seneca Partners manages Seneca Health Partners, a venture capital fund dedicated to emerging healthcare companies located throughout Middle America.  More Info

Charles Resnick
Managing Partner, Inflexion Fund
Charles is an accomplished business executive with a 25-year career in global general management, operations, financial management, and strategic relationships in the technology, banking and consumer packaged goods sectors. Charles has had senior management positions in the United States, South America, Mexico, and Western Europe with Dank Business Systems, Tropicana Products, Mellon Bank, PepsiCo and The Procter & Gamble Company.
More Info